§ Mr. RedmondTo ask the Secretary of State for Health what considerations underlie her policy not to hold information centrally in respect of the new chemical entity products made available to the national health service since February 1993 that would have been covered by the selected list scheme; if she will make it her policy in future to hold a list centrally; and if she will make a statement.
§ Dr. MawhinneyAll drugs, including those containing a new chemical entity, must be licensed by the Medicines
200W
Table A: number of children in secure accommodation at 31 March 1992, admitted subject to a care order in criminal proceedings, remanded or detained, by local authority and legal status Subject to care order made in criminal proceedings Remanded Section 23, CYPA11969 Remanded to LA accommodation Detained Section 38(6) CYPA1 Act 1984 Detained S53 CYPA Act 1933 England 15 4 69 1 81 Avon 1 — 3 — 9 Cambridgeshire — — — — 2 Cheshire — — 4 — 2 Coventry — — 5 — — Derbyshire — — 2 — 1 Devon 1 — 1 — 4 Durham 7 3 6 — 8 East Sussex — — 1 — — Hammersmith — 1 6 — 6 Control Agency before they may be prescribed for patients under the national health service. Once a product is licensed it is the manufacturer who decides when to bring it on to the market. Manufacturers do not need to notify the Department of this decision.